Subclasses of cyclic GMP-specific phosphodiesterase and their role in regulating the effects of atrial natriuretic factor.
- 1 May 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 15 (5), 528-540
- https://doi.org/10.1161/01.hyp.15.5.528
Abstract
Two subclasses of cyclic guanosine monophosphate (GMP)-specific phosphodiesterases were identified in vascular tissue from several beds. The activity of one subclass (phosphodiesterase IB) was stimulated severalfold by calmodulin and selectively inhibited by the phosphodiesterase inhibitor TCV-3B. The activity of the other subclass (phosphodiesterase IC) was not stimulated by calmodulin and was selectively inhibited by the phosphodiesterase inhibitor M&B 22,948. To assess the involvement of both subclasses in regulating cyclic GMP-dependent responses, the ability of TCV-3B and M&B 22,948 to potentiate the in vitro and in vivo responses to the endogenous guanylate cyclase stimulator atrial natriuretic factor (ANF) was evaluated. Both TCV-3B and M&B 22,948 relaxed isolated rabbit aortic and pulmonary artery rings and also potentiated the relaxant effect of ANF. In addition, both inhibitors produced small increases in urine flow and sodium excretion in anesthetized rats and potentiated the diuretic and natriuretic responses to exogenous ANF. M&B 22,948 (30 micrograms/kg/min) produced a threefold increase in the natriuretic response to simultaneously administered ANF, and TCV-3B (10 micrograms/kg/min) produced a twofold increase in the response to ANF. The results of the present experiments suggest that both the calmodulin-sensitive and calmodulin-insensitive subclasses of cyclic GMP-specific phosphodiesterase play a role in regulating the in vitro and in vivo response to ANF.This publication has 32 references indexed in Scilit:
- Atrial natriuretic peptide levels during development of chronic heart failure after myocardial infarction in ratsLife Sciences, 1987
- Atrial Natriuretic Factors Stimulate Accumulation and Efflux of Cyclic GMP in C6–2B Rat Glioma and PC12 Rat Pheochromocytoma Cell CulturesJournal of Neurochemistry, 1987
- Regulation of cAMP concentration by calmodulin-dependent cyclic nucleotide phosphodiesteraseBiochemistry and Cell Biology, 1986
- Comparing the Means of Several GroupsNew England Journal of Medicine, 1985
- Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loadingKlinische Wochenschrift, 1985
- Atrial Natriuretic Hormone, the Renin–Aldosterone Axis, and Blood Pressure–Electrolyte HomeostasisNew England Journal of Medicine, 1985
- Atriopeptins as cardiac hormones.Hypertension, 1985
- A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug SelectivityJournal of Medicinal Chemistry, 1985
- The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclaseFEBS Letters, 1985
- Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.Hypertension, 1984